On the 21st of April 2014, Cubist Pharmaceuticals, Inc. announced that it has submitted a new drug application (NDA) to the U.S. Food and Drug
Day: April 28, 2014
This podcast and the blog are for general informational purposes only and do not constitute the practice of medicine, nursing, or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this blog, podcast or materials linked from this blog or podcast is at the user’s own risk. The content of this site is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.